Please login to the form below

Not currently logged in
Email:
Password:

Trial success for Forest's depression drug

Forest Laboratories has said preliminary results from a phase III trial of major depressive disorder treatment, levomilnacipran, indicate the drug achieved a statistically significant improvement in patients compared to placebo

Forest Laboratories has said preliminary results from a phase III trial of major depressive disorder treatment, levomilnacipran, indicate the drug achieved a statistically significant improvement in patients compared to placebo.

The drug's efficacy was based on the primary endpoint of a patient's change from baseline to end of week 8 in the Montgomery-Asberg Depression Rating Scale-Clinician Rated (MADRS-CR) total score.

Levomilnacipran is co-developed by Forest and France-based laboratory Pierre Fabre Medicament.

"These positive phase III results are very encouraging and support the continued research of levomilnacipran in adult patients with major depressive disorder," said Dr Marco Taglietti, senior vice president, R&D, and president, Forest Research Institute.

Further analysis of the study data is ongoing, with two additional placebo-controlled phase III studies expected at the end of 2011 and in spring 2012, respectively.

18th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics